Quick Heal Technologies · NSE: QUICKHEAL · BSE: 539678

Q4 FY25 results · Jan–Mar 2025

Quick Heal Technologies reported revenue from operations of ₹65.14 crore (down 18.6% from Q4 FY24) and net loss of ₹3.25 crore for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY25Q4 FY24YoYQ3 FY25QoQ
Revenue from operations65.1480.03−18.6%70.61−7.7%
Other income5.606.82−17.9%4.91+14.1%
Total income70.7486.85−18.5%75.52−6.3%
Profit before tax(6.57)13.55Turned loss(2.31)Loss widened
Net profit for the period(3.25)14.04Turned loss0.11Turned loss
EPS, basic (₹)(0.60)2.63Turned loss0.02Turned loss
Net margin (%)-5.017.50.2
Standalone · ₹ crore
ItemQ4 FY25Q4 FY24YoYQ3 FY25QoQ
Revenue from operations65.1380.03−18.6%70.54−7.7%
Other income5.546.82−18.8%4.91+12.8%
Total income70.6786.85−18.6%75.45−6.3%
Profit before tax(6.00)13.54Turned loss(2.20)Loss widened
Net profit for the period(2.68)14.03Turned loss0.22Turned loss
EPS, basic (₹)(0.50)2.63Turned loss0.04Turned loss
Net margin (%)-4.117.50.3
Consolidated
Filed with BSE
04 Jul 2025, 14:19 IST
Board meeting
06 May 2025
Period
01 Jan 2025 to 31 Mar 2025
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
04 Jul 2025, 14:19 IST
Board meeting
06 May 2025
Period
01 Jan 2025 to 31 Mar 2025
Review status
Audited
Source
XBRL filing on BSE